BackFresenius Medical Care AG Overview
Fresenius Medical Care AG - ADR

Fresenius Medical Care AG Target Price

Where could FMS trade next? Consensus target price: $24.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.63

Average Target Price

$23.570.3% downside

3 analysts in the last 4 months

High: $25.8 | Low: $19.9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06BernsteinSusannah Ludwig$25.89.2% upsideOpen
2026-08-05Truist Financial$255.8% upsideOpen
2026-07-28BNP Paribas$19.915.8% downsideOpen
2026-01-05Truist Financial$2818.5% upsideOpen
2024-05-15Truist FinancialDavid MacDonald$241.6% upsideOpen
2023-01-02JefferiesJames Vane-Tempest$11.750.5% downsideOpen
2022-06-22Truist Financial$2714.3% upsideOpen

Fresenius Medical Care AG (FMS) FAQ

Fresenius Medical Care AG's target price stands at $24. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $24 for FMS implies 0.3% downside versus today's price ($23.63). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Fresenius Medical Care AG's target price evolved across reporting periods, while the comparison chart places FMS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Fresenius Medical Care AG's reading of $24 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.